Skip to content
FDA Staff Question Peptides Backed by Kennedy Ahead of Review
via Business of Fashion · June 30, 2026

FDA Staff Question Peptides Backed by Kennedy Ahead of Review

Reviewers at the agency said there was limited clinical evidence and human trials supporting peptides, sharply diverging with US health chief Robert F. Kennedy's plan to deregulate them.

The Story

US FDA ​staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in ‌stark contrast to Health Secretary Robert F. Kennedy, Jr., who has publicly endorsed the compounds and said he is a “big fan.”

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.

Original report
Business of Fashion
Read full story
Continue reading
Loading…